US Exchange Filings

Theriva Biologics Announces 1-for-30 Reverse Stock Split Effective December 1

Theriva Biologics will consolidate its shares 30-for-1, aiming to meet NYSE American’s minimum share-price requirements. The move will sharply reduce shares outstanding and authorized, while leaving investors’ proportional ownership unchanged aside from fractional-share rounding.

Theriva Biologics will combine every 30 shares of its common stock into one share in a reverse stock split, effective after the market closes on December 1. The company says the move is intended to help it meet NYSE American’s minimum share-price requirements.

Trading under the ticker TOVX is expected to begin on a split-adjusted basis when the market opens December 2. The ticker will remain the same, but the stock will have a new CUSIP number.

Key details

  • Theriva’s outstanding common shares are expected to fall from 45,892,668 to about 1,529,756, before accounting for fractional-share adjustments.
  • The number of authorized common shares will also be reduced proportionally, from 350 million to about 11.67 million.
  • Holders will receive one post-split share for every 30 shares they own. No action is required for shares held through a brokerage account.
  • Rather than issue fractional shares, the company will round up holders’ resulting fractional amounts to the next whole share.
  • The split will also adjust the share counts and exercise prices for outstanding warrants and stock options, and the shares reserved under the company’s equity plans.
  • The board approved the split on November 13. Theriva says it can implement the change without a shareholder vote under Nevada law.
  • Holders of paper stock certificates will receive instructions from the company’s transfer agent about exchanging them if they wish.

What changes for shareholders

The split reduces the number of shares each investor holds and increases the per-share price proportionally at the time of the adjustment; it does not, by itself, change the company’s overall value or an investor’s proportional ownership. The authorized-share count is being reduced in the same ratio, rather than left unchanged.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.